Modeling the Impact of Biomarker-Guided Versus ASCVD Risk-Guided Drug Treatment in US Adults With Stage 1 Hypertension: The National Health and Nutrition Examination Survey, 1999 to 2004.
Foti, Kathryn, Dan Wang, Olive Tang, Natalie R Daya, Yvonne Commodore-Mensah, Stephen P Juraschek, Robert Christenson, Elizabeth Selvin, and John W McEvoy. 2024. “Modeling the Impact of Biomarker-Guided Versus ASCVD Risk-Guided Drug Treatment in US Adults With Stage 1 Hypertension: The National Health and Nutrition Examination Survey, 1999 to 2004.”. Hypertension (Dallas, Tex. : 1979).